RYAH Announces Key Promotions and New Hires

RYAH Announces Key Promotions and New Hires

TORONTO, ON / ACCESSWIRE / June 1, 2022 / RYAH GROUP Inc. (CSE: RYAH or the “Corporation”) is pleased to announce the appointment of Jordan Medley as Vice President of Global Product, Sophie Kleshchuk as Deputy Vice President of Global Operations, Ramon Torres as Senior Software Engineer and Harry Tetteh as Associate ‘research, sales and operations. .

C. Jordan Medley has been a founding member of RYAH since the inception of Potbotics Inc. in 2015, with which RYAH Medtech Inc. merged. Jordan was the human intelligence that propelled the patented artificial intelligence (AI) that underlies RYAH’s big data ecosystem. He led most of RYAH’s IoT device hardware development and various medical device approval initiatives, such as Canada, New Zealand and the EU (ongoing). Jordan established successful manufacturing supply processes with key international partners, including the UK Clinical Trials Partner (LVL Clinic) and the French partner DelleD. Jordan holds a bachelor of science degree in sports management from Ithaca College, New York, and resides in the New York metropolitan area. Jordan is passionate about health and fitness and has a well-deserved reputation as a cannabis expert.

Sophie (Sofiya) Kleshchuk has served as a key member of the RYAH team, critical to the company’s growth and operational excellence, since joining in 2019. Sophie has made significant contributions to business development. the management of stakeholder relations and the administrative governance of the group and its subsidiaries. Sophie previously held various roles in business development, marketing, public relations, media management, and software development. He earned a master’s degree in international communication and global media from the Taras Shevchenko National University in Kyiv, Ukraine. In addition, Sophie received a Certificate in Innovation and Entrepreneurship from the University of A Coruna, Spain. Sophie is also a former member of the Ukrainian National Swimming Team and has a national rank of Sports Teacher.

Ramon Torres has been a major contributor to RYAH’s technology development team for several years, and now joins as a regular employee. Ramon played an important role in designing and building the underlying infrastructure that drives the information and data analysis derived from RYAH’s certified medically IoT-connected devices. With the expansion of its role, Ramon will continue to grow and improve RYAH’s data capture and AI capabilities to establish RYAH as the industry’s leading data pioneer. He holds a bachelor’s degree in accounting and information technology from the University of Puerto Rico. Ramon is headquartered in Silicon Valley, CA.

Harry Tetteh joins the RYAH Group as a Research, Sales and Operations Partner, in which he will help identify and develop opportunities to expand into new markets and bring RYAH’s vision to life. Harry brings more than a decade of business technology sales experience with Oracle, and a world-renowned experience as an expert in global multimedia collaboration, winning the ThinkQuest International Competition organized by the Oracle Education Foundation in 2008. Harry’s academic background includes a master’s degree in science. degree in Educational and Instructional Technology from National University (California) and a Certificate in Innovation and Entrepreneurship from Stanford University Graduate School of Business. Harry works and lives with his family in Fitchburg, Massachusetts.

About RYAH Group Inc.

RYAH is a technology and big data company that enables valuable AI-driven predictive analytics of the effectiveness of herbal medicines and other nutraceuticals administered through its range of innovative IoT-connected medical devices such as inhalers, patches, and pens. . RYAH’s robust big data platform, the only one of its kind in this space, aggregates and analyzes HIPAA-compliant patient data, helping physicians and patients customize treatments, control doses, and predict and control better the results. Beyond specific medical uses, RYAH supports the use of a variety of nutraceuticals by users for welfare purposes, including personal enjoyment, that is, recreational use. The collection and analysis of objective and subjective data of use, together with the data derived from the processing of the natural language of various scientific and other relevant literatures, will allow to obtain very valuable knowledge for a wide variety of stakeholders, starting with the users themselves. extending to physicians. medical scientists, insurance providers, dispensaries, licensed producers, producers, pharmaceutical producers and more. Through the above, a relentless focus on innovation and a development history of winning collaborative partnerships among relevant industries, RYAH is continuously building a unique and highly valuable IP portfolio and big data assets ready for be monetized.

AI: Artificial Intelligence

IoT: Internet of Things

HIPAA: Health Insurance Portability and Liability Act

IP: Intellectual Property

R&D: Research and Development

NFT: non-fungible token


This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “estimate”, “continue”, “anticipate”, “attempt”, “expect”. , “in process” and other similar expressions constituting “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the company’s current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties that include, but are not limited to, our expectations regarding market acceptance of our products, our strategy for developing new products and improving the capabilities of existing products, and our strategy for which relates to research and development. , the impact of competitive products and prices, new product development, and uncertainties related to the regulatory approval process. These statements reflect the Company’s current views regarding future events and are subject to certain risks and uncertainties and other risks detailed from time to time in the Company’s ongoing statements to securities regulators, which may be found. at www.sedar.com. Actual results, events, and performance may differ substantially. Readers are cautioned not to unduly trust these forward-looking statements. The Company assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by applicable securities laws.

For more information contact:

Dr. David R. Richards, General Manager: [email protected]
Sr. François C. Desrosiers, CFO: [email protected]
+ 1.438-874-0558

SOURCE: RYAH Medtech Inc.

View the source version on accesswire.com:

Source link

Related post

EDUCAUSE 2022: How Data Collection Can Improve Student and Faculty IT Support

EDUCAUSE 2022: How Data Collection Can Improve Student and…

At Indiana University, Gladdin said, to make life easier for students and faculty, they implemented a course template for the Canvas…
UGC, AICTE warn students against online PhD programmes offered by EdTech platforms | Latest News India

UGC, AICTE warn students against online PhD programmes offered…

The University Grants Commission (UGC) and the All India Council for Technical Education (AICTE) on Friday issued a joint advisory against…
UGC, AICTE warn students against online PhD programmes offered by EdTech platforms | Latest News India

UGC, AICTE warn students against online PhD programmes offered…

The University Grants Commission (UGC) and the All India Council for Technical Education (AICTE) on Friday issued a joint advisory against…

Leave a Reply

Your email address will not be published.